Isabelle Rydén

8PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersPeople with disabilityEpidemiological modellingRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 22, 2025
Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation.

Florien W Boele, Sé M Frances, Amélie Darlix

|Jul 15, 2024
Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals' perspectives.

Florien Boele, Lena Rosenlund, Sara Nordentoft

|May 13, 2024
Global health status and fatigue score in isocitrate dehydrogenase-mutant diffuse glioma grades 2 and 3: A longitudinal population-based study from surgery to 12-month follow-up.

Tomás Gómez Vecchio, Isabelle Rydén, Anneli Ozanne

|Mar 20, 2023
Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden.

Liv Cathrine Heggebø, Ida Maria Henriksen Borgen, Hillevi Rylander

|May 13, 2022
Neuropsychological functioning in childhood cancer survivors following cranial radiotherapy - results from a long-term follow-up clinic.

Isabelle Rydén, Erik Fernström, Birgitta Lannering

|Mar 09, 2021
Psychotropic and anti-epileptic drug use, before and after surgery, among patients with low-grade glioma: a nationwide matched cohort study.

Isabelle Rydén, Erik Thurin, Louise Carstam

Pageof 2

Frequent Collaborators

3 joint publications

Asgeir Store Jakola

2 joint publications

Louise Carstam

2 joint publications

Anja Smits

2 joint publications

Florien W Boele